In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study. (nature.com)

Authors: An N … Li C Journal: Nature Medicine Published: 2026-04-01 DOI: https://doi.org/10.1038/s41591-026-04244-6